PIN1 and breast carcinoma: To evaluate Pin1 as a potential treatment target for Her2+ breast cancer, we set out first to examine the prevalence of Pin1 expression in Her2-positive breast cancer, and found co-expression in 62% of Her2+ breast cancer specimen, suggesting that simultaneous inhibition of Pin1 and Her2 might be effective (Fig. 1, Tab 1).